Phase II study of XL184 (cabozantinib) in recurrent or metastatic endometrial cancer: A trial of the PMH, Chicago, and California Phase II Consortia. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wilson, Michelle
  • Dhani, Neesha C
  • Hirte, Holger
  • Welch, Stephen
  • Steed, Helen
  • Martin, Lainie P
  • Lheureux, Stephanie
  • Martin-Lorente, Cristina
  • Mackay, Helen
  • Butler, Marcus O
  • Wang, Lisa
  • Quintos, Judy
  • Allen, Katie
  • Roman, Lynda
  • Wright, John Joseph
  • Oza, Amit M

publication date

  • May 20, 2014